ImmunityBio, Inc. , a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA (nogapendekin alfa inbakicept) clinical program in non-small cell lung cancer (NSCLC) ...

The company said that responding patients lived longer overall, with a median survival of 16.2 months. ・The data come from ...

CK0804 is a first in class, CXCR4hi Treg therapeutic designed to preferentially traffic towards its ligand CXCL12 over ...

CD4 counts show how strong your immune system is; lower counts mean a weaker immune response. The CD4 percentage shows what part of your white blood cells are CD4 cells and helps check how strong your ...

KETV NEWSWATCH SEVEN STARTS WITH BREAKING NEWS. WE ARE FOLLOWING SEVERAL BREAKING STORIES AT THIS HOUR. THE FIRST LINCOLN POLICE ARREST AN ENGLISH LEARNER TEACHER ON MULTIPLE COUNTS OF SEX ABUSE.

The U.S. is experiencing its worst resurgence of measles in more than three decades, and is at risk of losing its measles elimination status. A team at the Yale School of Public Health has been ...

Executions rose dramatically in the U.S. this year, and the Gulf South played a key role, a new report shows. While Louisiana, Mississippi and Alabama all put people to death, Alabama was in a group ...

DC’s All In publishing initiative gives powerhouse creators the chance to write some of the label’s most iconic heroes without the constraints of a pre-established continuity. Spearheaded by comics ...